Evidence map›Paper›PMID 22989765›Full record

ReviewAdvances in genetics2012

The genetics of dystonias.

Mark S LeDoux

Abstract readReview
In one paragraph

Review in Advances in genetics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
5.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Risk Factor Genes in Patients with Dystonia: A Comprehensive Review.Tremor and other hyperkinetic movements (New York, N.Y.) · 2018
    Review
  5. Deep brain stimulation for dystonia: a novel perspective on the value of genetic testing.Journal of neural transmission (Vienna, Austria : 1996) · 2017
    Review
  6. Update on the Genetics of Dystonia.Current neurology and neuroscience reports · 2017
    Review
  7. Article
  8. Article
  9. Article
  10. Blepharospasm in a multiplex African-American pedigree.Journal of the neurological sciences · 2016
    Article
  11. Diagnosis and treatment of dystonia.Neurologic clinics · 2015
    Review
  12. Article
  13. Recent advances in the genetics of dystonia.Current neurology and neuroscience reports · 2014
    Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Mark S LeDouxDepartment of Neurology, University of Tennessee Health Science Center, Memphis, TN, USA.
University of Tennessee Health Science Center · US

Funding

Dystonia CoalitionU54NS065701 · NINDS · EMORY UNIVERSITY · PI JINNAH, HYDER A · 2009 to 2014
$7.0M
Dystonia CoalitionU54TR001456 · NCATS · EMORY UNIVERSITY · PI JINNAH, HYDER A · 2015 to 2016
$2.5M
The Role of THAP1 in DystoniaR01NS069936 · NINDS · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI LEDOUX, MARK S · 2010 to 2013
$1.3M
Mutant Gene Identification in the Dystonic RatR01NS048458 · NINDS · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI LEDOUX, MARK S · 2005 to 2008
$800k
NCATS NIH HHS U54 TR001456NINDS NIH HHS 1U54NS065701NINDS NIH HHS R01 NS048458NINDS NIH HHS R01NS048458NINDS NIH HHS R01 NS069936NINDS NIH HHS R01NS069936NINDS NIH HHS U54 NS065701
6 · The paper itself

Abstract

Dystonia has been defined as a syndrome of involuntary, sustained muscle contractions affecting one or more sites of the body, frequently causing twisting and repetitive movements or abnormal postures. Dystonia is also a clinical sign that can be the presenting or prominent manifestation of many neurodegenerative and neurometabolic disorders. Etiological categories include primary dystonia, secondary dystonia, heredodegenerative diseases with dystonia, and dystonia plus. Primary dystonia includes syndromes in which dystonia is the sole phenotypic manifestation with the exception that tremor can be present as well. Most primary dystonia begins in adults, and approximately 10% of probands report one or more affected family members. Many cases of childhood- and adolescent-onset dystonia are due to mutations in TOR1A and THAP1. Mutations in THAP1 and CIZ1 have been associated with sporadic and familial adult-onset dystonia. Although significant recent progress had been made in defining the genetic basis for most of the dystonia-plus and heredodegenerative diseases with dystonia, a major gap remains in understanding the genetic etiologies for most cases of adult-onset primary dystonia. Common themes in the cellular biology of dystonia include G1/S cell cycle control, monoaminergic neurotransmission, mitochondrial dysfunction, and the neuronal stress response.

Indexed as

Apoptosis Regulatory ProteinsDNA-Binding ProteinsDystoniaHumansMolecular ChaperonesMutationNeurodegenerative DiseasesNuclear ProteinsApoptosis Regulatory ProteinsCiz1 protein, humanDNA-Binding ProteinsMolecular ChaperonesNuclear ProteinsTHAP1 protein, humanTOR1A protein, human

Identifiers

PMID22989765
PMCPMC4879967
OpenAlexW2408521271

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.